Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90/ED99 of oliceridine + propofol for painless gastroscopy
ChiCTR2600118736Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dali University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine and propofol in procedural pain and Procedural anxiety, sponsored by The First Affiliated Hospital of Dali University. Primary endpoint: Inhibition of responses to gastroscope insertion (cough and movement). Started Feb 2026; status: completed.
02
Drugs
oliceridinepropofol
03
Conditions
procedural painProcedural anxiety
Beyond the preview
Go deeper on ChiCTR2600118736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118736.